Skip to main content
. 2011 Nov;96(11):1636–1643. doi: 10.3324/haematol.2011.041079

Figure 2.

Figure 2.

Survival data of patients with cytotoxic molecule-positive CHL compared with those with cytotoxic molecule-negative CHL and cytotoxic molecule-positive PTCL-N. Prognosis of patients with cytotoxic molecule-positive CHL (thick line) is significantly poorer than that of patients with cytotoxic molecule-negative CHL (dotted line), and better than that of patients with cytotoxic molecule-positive PTCL-N (thin line).